| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 02/15/2006 | CN1733130A Process for extracting litchi polyphenol from litchi |
| 02/15/2006 | CN1733056A Fermented soybean and VC composite product and its preparation process |
| 02/15/2006 | CN1733050A Asiabell polysaccharide tablet of asiabell effective ingredient |
| 02/15/2006 | CN1732982A Powder for relieving herbicide intoxication |
| 02/15/2006 | CN1241576C Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 02/14/2006 | US6998503 crystallized as an anhydrous, stoichiometric 1.5 HCl salt; inhibiting or modulating nitric oxide synthesis |
| 02/14/2006 | US6998388 High density lipoprotein against organ dysfunction following haemorrhagic shock |
| 02/14/2006 | CA2178605C Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors |
| 02/09/2006 | WO2002088316A3 G-protein coupled receptors |
| 02/09/2006 | US20060030605 Pharmaceutical compounds |
| 02/09/2006 | US20060029687 comprises a carrier essentially formed of water, ethoxydiglycol and propylene glycol; anti-oxidant; high stirring speed provides for micronizaton of the components, which is responsible for the stability of the solutions |
| 02/08/2006 | EP1309328A4 Cox-2 inhibitors and the prevention of the side effects of radiation therapy |
| 02/08/2006 | CN1731999A Benzothiazole derivatives |
| 02/08/2006 | CN1730479A Aloe dihydro-coumarin and its separation method and uses |
| 02/08/2006 | CN1240671C N-(l- deoxyglucose alcoho1-1-yl) amino acid and producing process and use thereof |
| 02/08/2006 | CN1240420C Detoxicant |
| 02/08/2006 | CN1240390C Biologic converted ginseng composition and preparing process thereof |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | CA2119783C Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | DE202005017617U1 Ointment and/or gel composition, useful for preventing allergies due to chromate, comprises tin II-ions in a conventional protective ointment or a conventional protection gel based on fat |
| 02/01/2006 | EP1621198A2 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
| 02/01/2006 | EP1621194A1 Active oxygen eliminator originating in natural material and use of the same |
| 02/01/2006 | EP1430144A4 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER |
| 02/01/2006 | EP1328266B1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 02/01/2006 | CN1726927A Active function of ostrich blood |
| 02/01/2006 | CN1726915A Nasal cavity taken drug system and combination of naloxone hydrochloride and preparation method |
| 02/01/2006 | CN1239482C Positive modulators for nicotinic receptor agonists |
| 02/01/2006 | CN1239154C 5-HT IA receptor subtype agonist |
| 01/31/2006 | US6992067 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 01/31/2006 | US6992061 Removing endotoxin lipopolysacchardie from preparation of alpha-1-acid glycoprotein (orosomucoid) by contact with a finely divided non-toxic resin such as fumed silica |
| 01/31/2006 | US6991817 Acid-modified arabinogalactan protein composition |
| 01/26/2006 | US20060020138 E.g., 3-arylmethyl-7-hydroxy-coumarins as intermediates; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 01/26/2006 | US20060019930 Treatment and prevention of tissue damage |
| 01/26/2006 | US20060018983 Composition containing green-yellow vegetables and light-colored vegetables |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1617844A1 Treatment of neurological conditions |
| 01/25/2006 | EP1372627B1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/25/2006 | EP1309251A4 Selenium diet supplement |
| 01/25/2006 | EP1267901B1 Compositions suitable for the treatment of damage caused by ischemia/reperfusion or oxidative stress |
| 01/25/2006 | CN1726049A Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 01/25/2006 | CN1724684A Preparation method of oligopeptide with eliminating free radical activity |
| 01/25/2006 | CN1723926A Traditional Chinese medicine liquor and preparation method thereof |
| 01/25/2006 | CN1723890A Anti-oxidation medicine |
| 01/25/2006 | CN1238008C Medicine or function food for promoting human lead discharge and preparing method thereof |
| 01/25/2006 | CN1237995C Drug for ripening and eliminating abnormal black balliary body fluid and its preparation method |
| 01/25/2006 | CN1237974C Ursolic acid dripping pills and its preparation process |
| 01/24/2006 | US6989401 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products |
| 01/24/2006 | US6989397 Iron chelators and uses thereof |
| 01/24/2006 | US6989372 medicaments intended to increase the intracellular and/or extracellular level of glutathione (GSH); for example, N-(N-Acetyl-L-cysteinyl)-S-acetylcysteamine; hiv treatment |
| 01/24/2006 | CA2347117C Methods for inhibiting diabetic complications |
| 01/24/2006 | CA2195747C New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 01/19/2006 | US20060014722 Per (3,6-anhydro) cyclodextrin derivatives, their preparation and use thereof for separating ions, in particular chromium and manganese anions |
| 01/19/2006 | US20060014718 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 01/19/2006 | US20060011891 Nadh/nadph-containing compound |
| 01/18/2006 | EP1616878A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2006 | EP1616869A1 Substituted porphyrins and their therapeutic use |
| 01/18/2006 | EP1214064A4 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 01/18/2006 | CN1237066C Antihyperglycemic and oxidation resistant health products and preparing process thereof |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987128 Compounds of the N-acylamino amide family, compositions comprising same, and uses |
| 01/17/2006 | US6987126 Neutralizing agent for clostridium bacterial neurotoxins and preparation method thereof |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987107 Method of treating incontinence |
| 01/12/2006 | WO2006004458A1 Biologically active astaxanthin-containing agent |
| 01/12/2006 | US20060009534 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009494 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1613294A2 Peptides and derivatives thereof as inhibitors of oxidative-induced degradation phenomena and compositions containing them |
| 01/11/2006 | CN1718238A Application of nerve growth factor prepd. in medicine for treating tardive neuropathy due to toxication by organophosphorus pesticide |
| 01/11/2006 | CN1718216A Method for increasing content of flavone in extracting ginkgo leaves by using affinity ultrafiltration |
| 01/11/2006 | CN1235905C Rhodiola sacra glycoside derivative and its preparation method and use |
| 01/11/2006 | CN1235640C Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984636 Mitochondrially targeted antioxidants |
| 01/05/2006 | US20060004080 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof a JNK inhibitors and compositions and methods related thereto |
| 01/05/2006 | DE202004013521U1 Composition containing beta-glucan and nucleotide, useful, particularly in animals, for stimulation of the immune system, e.g. during convalescence |
| 01/04/2006 | EP1611898A1 Composition for the prevention and treatment of cellulitis |
| 01/04/2006 | EP1611895A1 Use of n-acetyl-d-aminoglycosamine in treatment of organ lesions related to toxicosis of drugs or chemicals |
| 01/04/2006 | EP1610809A2 Vault and vault-like carrier molecules |
| 01/04/2006 | EP1610783A2 Modulation of cell death |
| 01/04/2006 | EP1610773A2 Use of compounds for the prevention of drug-induced cell toxicity |
| 01/04/2006 | EP1351688A4 Urotensin-ii receptor antagonists |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | CN1717242A Process for the preparation of antioxidants from dillenia indica |
| 01/04/2006 | CN1234357C Antihypersensitive combination of valsartan and calcium channel blocker |
| 01/03/2006 | US6982248 Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
| 01/03/2006 | US6982099 Composition and method for smoke detoxification |
| 01/03/2006 | US6982088 Vaccine composition and stabilization method using high molecular weight PVP |
| 01/03/2006 | CA2264901C Association of no syntase inhibitors with trappers of oxygen reactive forms |
| 12/29/2005 | WO2005123120A1 Sustained release vaccine composition |
| 12/29/2005 | US20050288359 Agents and methods for the treatment of disorders associated with oxidative stress |